Status:
COMPLETED
PREPARE-IBD: Physician Responses to Disease Flares and Patient Adaptation in Relation to Events in Inflammatory Bowel Disease During COVID-19 Pandemic
Lead Sponsor:
Hull University Teaching Hospitals NHS Trust
Conditions:
Inflammatory Bowel Diseases
Coronavirus Infection
Eligibility:
All Genders
16-100 years
Brief Summary
To find out what adaptations have been made by Inflammatory bowel disease physicians and patients in relation to therapies in flaring IBD patients during severe acute respiratory syndrome 2-COV and wh...
Detailed Description
An observational, retrospective, case-controlled study to determine the status of IBD during development of COVID-19 symptoms/positive COVID-19. The aim is to describe the adaptations in therapies for...
Eligibility Criteria
Inclusion
- Patients with IBD +/- flare +/- COVID 19 positivity
Exclusion
- Patients below 16
- Patient with inactive IBD
Key Trial Info
Start Date :
May 22 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 31 2022
Estimated Enrollment :
3728 Patients enrolled
Trial Details
Trial ID
NCT04410484
Start Date
May 22 2020
End Date
August 31 2022
Last Update
November 4 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Gastroenterology, Hull Royal Infirmary, Hull University Teaaching Hospitals NHS Trust
Hull, United Kingdom